Affiche Présentation orale Soumissions
A triple-drug nano-therapy targeting breast cancer cells, cancer stem cells, and tumor vasculature
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, contributing to the majority of breast cancer-related death. While chemotherapeutics (such as, paclitaxel) are the mainstay of systemic treatment for TNBC, they also enrich a subpopulation of cells with tumor-initiating capacity and stem-like characteristics called cancer stem cells (CSCs). Lire la suite…